Expert committee on introduction of incretin-based therapy in Russia: advance and failure
Short resume of expert committees meeting about problems of using of incretin-based therapy in Russian Federation.
Saved in:
Main Author: | Editorial team Diabetes Mellitus |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/74a2e7af7ab642bd8b1cfc5da36a49b9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
by: Elena Valer'evna Biryukova
Published: (2014) -
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2012) -
Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia
by: Lyudmila Viktorovna Nedosugova, et al.
Published: (2014) -
The new drug saxagliptin is now registrated in Russia
by: Editorial team Diabetes Mellitus
Published: (2010) -
Vildagliptin: the first innovative DDP-4 inhibitor
by: Edvin Villkhauer
Published: (2010)